Scopus BioPharma Inc.
OTC: SCPS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alan D. Horsager
- Employees
- 13
- Headquarters
- New York City, United States
- IPO year
- 2020
- Market cap
- $16.8K
- Website
- https://scopusbiopharma.com
Loading SCPS…
Loading profile data…Frequently asked questions about SCPS
What does Scopus BioPharma Inc. (SCPS) do?
Scopus BioPharma Inc. is a biopharmaceutical company in the clinical development phase, dedicated to pioneering innovative treatments for serious diseases. Its core development programs are concentrated on immuno-oncology gene therapies designed to combat various forms of cancer. The company's offerings include the Duet Platform, which incorpora...
Where does SCPS trade?
Scopus BioPharma Inc. (SCPS) trades on the Other OTC.
What sector is SCPS in?
Scopus BioPharma Inc. (SCPS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Scopus BioPharma Inc.?
Alan D. Horsager is the chief executive officer of Scopus BioPharma Inc. (SCPS).
Where is Scopus BioPharma Inc. headquartered?
Scopus BioPharma Inc. is headquartered in United States.
Does SCPS pay a dividend?
Scopus BioPharma Inc. (SCPS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SCPS go public?
Scopus BioPharma Inc. (SCPS) completed its initial public offering in 2020.